NCT01869933View on ClinicalTrials.gov

Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Proliferative Diabetic Retinopathy (PDR)
Interventions
DRUG

OC-10X

Trial Locations (1)

1205

Bangladesh Eye Hospital, Dhaka

Sponsors
All Listed Sponsors
lead

OcuCure Therapeutics, Inc.

INDUSTRY